Skip to main content

Find Clinical Trials

Home
Conditions
Liposarcoma

Clinical trial condition

Liposarcoma

Explore clinical trials studying Liposarcoma. Study availability and eligibility vary by location and protocol.

121 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Liposarcoma trial results

Completed

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

NCT00474994

Conditions: AIDS-related Kaposi sarcoma, Adnexal Diseases, Adult Malignant Fibrous Histiocytoma of Bone, +75 more
Locations: Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075

Conditions: Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
Locations: Yale New Haven Hospital New Haven, Connecticut, United States

Columbia University - Herbert Irving Cancer Center New York, United States

New York University Cancer Institute New York, United States

M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

NCT00413322

Conditions: Adenoma, Adenosarcoma, Adnexal Diseases, +92 more
Locations: Mayo Clinic Arizona Scottsdale, Arizona, United States

University of Nebraska Omaha, Nebraska, United States

Portsmouth Regional Hospital Hematology/Oncology Clinic Portsmouth, New Hampshire, United States

View Trial Details

Completed

Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

NCT00093080

Conditions: Leiomyosarcoma, Liposarcoma, Metastases, +14 more
Locations: Not specified

View Trial Details

Completed

Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas

NCT01426633

Conditions: Leiomyosarcoma, Liposarcoma, Neoplasms, +5 more
Locations: Mannheim University Medical Center Mannheim, Germany

View Trial Details

Completed

Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery

NCT01477021

Conditions: Adult Liposarcoma, Adult Synovial Sarcoma, Liposarcoma, +10 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

NCT00061984

Conditions: Fibrosarcoma, Hemangiosarcoma, Histiocytoma, +24 more
Locations: Karl-Franzens-University Graz Graz, Austria

Institut Jules Bordet Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

U.Z. Gasthuisberg Leuven, Belgium

View all 41 locations

View Trial Details

Completed

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

NCT00060944

Conditions: Leiomyosarcoma, Liposarcoma, Neoplasm Metastasis, +9 more
Locations: Los Angeles, California, United States

Aurora, Colorado, United States

Coeur d'Alene, Idaho, United States

Park Ridge, Illinois, United States

View all 39 locations

View Trial Details

Completed

Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma

NCT00002641

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +60 more
Locations: Karl-Franzens-University Graz Graz, Austria

Institut Jules Bordet Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

Cliniques Universitaires Saint-Luc Brussels, Belgium

View all 45 locations

View Trial Details

Completed

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

NCT00132704

Conditions: Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +59 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details